Valuation: Circio Holding ASA

Market Cap 2.12B 225M 194M 182M 166M 309M 21.42B 317M 2.13B 835M 10.75B 843M 825M 35.68B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 2.12B 225M 194M 182M 166M 309M 21.45B 317M 2.13B 836M 10.76B 844M 826M 35.72B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Circio Holding ASA

1 day-2.52%
1 week+1.48%
Current month+8.54%
1 month+18.04%
3 months-19.96%
6 months+584.62%
Current year+664.61%
1 week 8.58
Extreme 8.58
9.56
1 month 7.36
Extreme 7.36
9.56
Current year 0.98
Extreme 0.978
14.46
1 year 0.55
Extreme 0.551999
14.46
3 years 0.48
Extreme 0.48
19.62
5 years 0.48
Extreme 0.48
236.7
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 19/10/2021
Director of Finance/CFO 58 06/03/2022
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Director/Board Member 79 30/06/2015
Director/Board Member 66 13/09/2015
Chairman 64 28/04/2020
Date Insider Type Main position Quantity % Market Cap.
30/11/21 Fiscal year

Chief Executive Officer

120,000 0.1386%
19/05/21 Buy

Director

21,299 0.0246%
03/12/20 Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
-2.52%+1.48%+1,383.34%-48.58% 224M
-1.90%+2.85%+62.82%+104.13% 70.07B
-3.21%-4.32%+31.85%+58.98% 52.87B
-2.05%-5.61%-3.18%+449.22% 27.02B
-1.27%-1.57%+45.90%+8.25% 23.61B
+1.05%-0.62%-18.00%-13.77% 23.38B
+3.81%+20.97%+266.37%+531.28% 19.43B
+0.10%+1.40%+35.36%-19.94% 18.75B
-0.95%-3.52%+19.93%+594.00% 15.85B
+1.24%-5.23%+33.75%+140.34% 12.7B
Average -0.57%+2.24%+185.81%+180.39% 26.39B
Weighted average by Cap. -1.09%+0.56%+51.37%+165.07%

Financials

2024 2025
Net sales - -
Net income 57.52M 6.1M 5.26M 4.95M 4.5M 8.39M 582M 8.6M 57.88M 22.67M 292M 22.87M 22.39M 969M -45.91M -4.86M -4.2M -3.95M -3.59M -6.7M -464M -6.86M -46.19M -18.09M -233M -18.26M -17.87M -773M
Net Debt -972K -103K -88.96K -83.61K -76.03K -142K -9.83M -145K -978K -383K -4.93M -387K -378K -16.37M 2.24M 238K 205K 193K 176K 328K 22.7M 335K 2.26M 885K 11.39M 893K 874K 37.81M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
10
Date Price Change Volume
14/08/26 NOK 8.900 -2.52% 2,435,422
13/08/26 NOK 9.130 -3.28% 4,917,446
12/08/26 NOK 9.440 +2.83% 4,753,930
11/08/26 NOK 9.180 +4.32% 4,913,207
10/08/26 NOK 8.800 +0.34% 3,454,966

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock